Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Asset Utilization Ratio (2019 - 2025)

BridgeBio Pharma's Asset Utilization Ratio history spans 7 years, with the latest figure at 0.52 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 85.32% year-over-year to 0.52; the TTM value through Dec 2025 reached 0.52, up 85.32%, while the annual FY2025 figure was 0.54, 78.74% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.52 at BridgeBio Pharma, up from 0.34 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.52 in Q4 2025 and bottomed at 0.0 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.1 (2022), against an average of 0.15.
  • The largest annual shift saw Asset Utilization Ratio plummeted 110.41% in 2021 before it skyrocketed 2552.92% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then skyrocketed by 883.85% to 0.11 in 2022, then tumbled by 86.52% to 0.02 in 2023, then soared by 1708.76% to 0.28 in 2024, then surged by 85.32% to 0.52 in 2025.
  • Per Business Quant, the three most recent readings for BBIO's Asset Utilization Ratio are 0.52 (Q4 2025), 0.34 (Q3 2025), and 0.24 (Q2 2025).